Issued 2026-09-16 at $5.21 · now $5.21 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, PYPD has typically landed between $3.74 and $6.46 — a range of −28.2% to +24.0% from the issuance price $5.21.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,531 overlapping 1 month windows · 2020-06-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($5.21) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where PYPD has typically landed a month from the 2026-09-16 close of $5.21 — the range is history, not a prediction.
- now $5.21 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $5.06 (-2.8%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $4.59–$5.54
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.74–$6.46
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2022-08-24 | −83.0% | −83.2% | +1.3% |
| 2022-08-23 | −82.7% | −82.7% | +3.9% |
| 2022-08-25 | −82.6% | −83.0% | +2.1% |
| 3 best | |||
| 2023-12-26 | +81.4% | +0.0% | +114.4% |
| 2023-12-28 | +72.5% | −0.5% | +102.6% |
| 2023-12-22 | +70.6% | −5.2% | +103.1% |
1,531 overlapping windows · 2020-06-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
10 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Akselbrad Dikla Czaczkes | director | Award / grant | 149,000 | 149,000 | Form 4 |
| 2026-07-15 | Barenholz Yechezkel | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-07-15 | BenAmram Joseph | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-07-15 | Dror-Darwish Nir | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-07-15 | Krinsky Itzhak | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-07-15 | Story Brooke | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-07-15 | Stein Robert Benjamin | director | Award / grant | 9,132 | 9,132 | Form 4 |
| 2026-05-11 | Hazan Dalit Fellous | officer | Award / grant | 75,000 | 75,000 | Form 4 |
| 2026-05-11 | Missulawin Jonathan | officer | Award / grant | 49,000 | 49,000 | Form 4 |
| 2026-05-11 | Warshavsky Ori | officer | Award / grant | 46,000 | 46,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.